# Andrzej Więcek

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrzej-wiecek/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,597 |
| Field | Renal Transplantation Outcomes and Treatments |
| h-index | 75 |
| i10-index | 317 |
| Last Known Institution | Medical University of Silesia |
| OpenAlex ID | https://openalex.org/A5044605455 |
| ORCID iD | https://orcid.org/0000-0002-8625-4188 |
| Works | 939 |

## Researcher papers

Showing 12 of 13.

- [The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial](https://scholariq.org/papers/the-effects-of-lowering-ldl-cholesterol-with-simvastatin-plus-ezetimibe-in/)
- [Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis](https://scholariq.org/papers/rosuvastatin-and-cardiovascular-events-in-patients-undergoing-hemodialysis/)
- [Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy](https://scholariq.org/papers/global-kidney-health-2017-and-beyond-a-roadmap-for-closing-gaps-in-care-research/)
- [Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus](https://scholariq.org/papers/results-of-an-international-randomized-trial-comparing-glucose-metabolism/)
- [Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement](https://scholariq.org/papers/kidney-disease-improving-global-outcomes-guidelines-on-anaemia-management-in/)
- [Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure](https://scholariq.org/papers/epidemiology-contributors-to-and-clinical-trials-of-mortality-risk-in-chronic/)
- [Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association](https://scholariq.org/papers/cardiovascular-complications-in-chronic-kidney-disease-a-review-from-the/)
- [A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis](https://scholariq.org/papers/a-randomized-controlled-double-blind-study-comparing-the-efficacy-and-safety-of/)
- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)
- [Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice](https://scholariq.org/papers/recommendations-for-the-use-of-tolvaptan-in-autosomal-dominant-polycystic-kidney/)
- [Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*](https://scholariq.org/papers/hypertension-in-dialysis-patients-a-consensus-document-by-the-european-renal-and/)
- [SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA](https://scholariq.org/papers/sglt-2-inhibitors-and-glp-1-receptor-agonists-for-nephroprotection-and/)

## Researcher topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Researcher university

- [Medical University of Silesia](https://scholariq.org/institutions/medical-university-of-silesia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.